| Last Trade On | Aug 25, 2026 | Day's Range | Rs 968.00 - 985.00 |
|---|---|---|---|
| Change | Rs -8.10 | 52 Week Range | Rs 755.56 - 1,224.00 |
| Open | Rs 978.49 | Volume | 55,433 |
| Close | Rs 970.39 | Previous Close | Rs 970.39 |
| Period | High | Low | Volume / Average |
|---|---|---|---|
| 1M | 1,010.69 | 970.39 | 364,200.00; Avg 18,210.00 |
| 3M | 1,060.42 | 961.21 | 2,024,673.00; Avg 33,744.55 |
| 6M | 1,060.42 | 755.56 | 4,127,105.00; Avg 34,975.47 |
| 1Y | 1,190.01 | 755.56 | 8,331,377.00; Avg 33,594.26 |
| Financial Year | 2025 | O/S Shares | 52.98m |
|---|---|---|---|
| Net Profit | Rs 4,119.31m | Market Cap | Rs 51,414.46m |
| EPS | 77.75 | P/E | 12.48 |
| Par Value | Rs 10.00 | Book Value | 248.57 |
| Net Worth | Rs 13,170.01m | Outstanding Shares | 52.98m |
| Dividend | Rs 50.00 | ROE | 31.28% |
| Dividend Yield | 5.15% | Dividend Payout | 64.31% |
| Earnings Yield | 8.01% | Sharia Compliant | No |
Yasir Mahmood Securities has partnered with TradingView for its charting solution.
A comprehensive trading platform which offers intuitive analytical tools,
stock screener and
real time economic calendar data
to track key financial events.
| Year | Individual | Institutions | Investment Companies | Foreign Investors | Government | Shareholders | Other |
|---|---|---|---|---|---|---|---|
| 2025 | 62.81% | 3.61% | 9.41% | 3.90% | 1.09% | 5,558.00 | 5.99% |
| 2024 | 62.53% | 5.98% | 9.51% | 5.29% | 1.09% | 4,379.00 | 5.17% |
| 2023 | 64.00% | 6.49% | 2.04% | 13.97% | 1.09% | 3,866.00 | 5.22% |
| 2022 | 63.38% | 2.02% | 1.92% | 14.10% | 1.09% | 3,519.00 | 4.74% |
| 2021 | 64.72% | 2.02% | 0.63% | 14.13% | 1.09% | 3,391.00 | 7.08% |
| 2020 | 65.06% | 2.05% | 0.00% | 1.85% | 0.00% | 3,408.00 | 17.73% |
| 2019 | 73.03% | 6.70% | 0.63% | 1.83% | 1.09% | 3,377.00 | 1.21% |
| 2018 | 74.27% | 4.41% | 0.00% | 1.73% | 1.09% | 3,408.00 | 0.11% |
| 2017 | 75.51% | 3.59% | 0.00% | 1.74% | 0.00% | 3,239.00 | 1.41% |
| 2016 | 79.83% | 3.63% | 0.00% | 1.77% | 0.37% | 3,102.00 | 0.91% |
| 2015 | 83.21% | 4.08% | 0.00% | 1.75% | 0.22% | 2,997.00 | 1.68% |
| 2014 | 79.27% | 5.18% | 5.16% | 10.39% | 0.00% | 3,278.00 | 0.00% |
| 2013 | 80.82% | 4.45% | 4.54% | 10.19% | 0.00% | 2,840.00 | 0.00% |
| 2012 | 79.16% | 6.02% | 12.98% | 1.84% | 0.00% | 2,956.00 | 0.00% |
| 2011 | 77.80% | 7.35% | 4.55% | 10.30% | 0.00% | 3,121.00 | 0.00% |
| 2010 | 77.40% | 7.79% | 4.52% | 10.29% | 0.00% | 3,223.00 | 0.00% |
| 2009 | 76.33% | 5.15% | 8.19% | 10.33% | 0.00% | 3,376.00 | 0.00% |
| 2008 | 74.58% | 5.15% | 18.78% | 1.49% | 0.00% | 3,375.00 | 0.00% |
| 2007 | 76.14% | 5.15% | 17.46% | 1.25% | 0.00% | 3,287.00 | 0.00% |
| 2006 | 79.70% | 5.15% | 13.82% | 1.33% | 0.00% | 3,146.00 | 0.00% |
| 2005 | 79.70% | 6.14% | 5.82% | 8.34% | 0.00% | 3,103.00 | 0.00% |
| 2004 | 78.42% | 7.47% | 12.78% | 1.33% | 0.00% | 3,005.00 | 0.00% |
| 2003 | 79.13% | 6.93% | 12.77% | 1.17% | 0.00% | 3,083.00 | 0.00% |
| 2002 | 88.72% | 6.43% | 4.85% | 0.00% | 0.00% | 2,989.00 | 0.00% |
| Company | Current Price | Change | Date |
|---|---|---|---|
| Abbot Laboratories (ABOT) | Rs 935.61 | 2.67% | Aug 25, 2026 |
| AGP Limited (AGP) | Rs 170.29 | -1.84% | Aug 25, 2026 |
| BF Biosciences Limited (BFBIO) | Rs 134.82 | -0.33% | Aug 25, 2026 |
| Citi Pharma Limited (CPHL) | Rs 76.18 | 0.87% | Aug 25, 2026 |
| Ferozsons Laboratories Limited (FEROZ) | Rs 361.68 | 0.22% | Aug 25, 2026 |
| Glaxosmithkline (GLAXO) | Rs 342.84 | -0.03% | Aug 25, 2026 |
| Glaxo Healthcare Pakistan (GSKCH) | Rs 120.23 | -3.20% | Jan 30, 2023 |
| Haleon Pakistan Limited (HALEON) | Rs 722.00 | -0.41% | Aug 25, 2026 |
| Highnoon Laboratories (HINOON) | Rs 970.39 | -0.83% | Aug 25, 2026 |
| Hoechst Pakistan Limited (HPL) | Rs 4,023.98 | -0.15% | Aug 25, 2026 |
| IBL Healthcare Limited (IBLHL) | Rs 48.30 | 0.75% | Aug 25, 2026 |
| IBL Healthcare Limited (r) (IBLHLR) | Rs 0.00 | 0.00% | Aug 27, 2026 |
| Liven Pharma Limited (LIVEN) | Rs 34.11 | 0.35% | Aug 25, 2026 |
| Liven Pharma Limited (r) (LIVENR) | Rs 0.00 | 0.00% | Aug 27, 2026 |
| Macter International Limited (MACTER) | Rs 273.21 | -0.65% | Aug 25, 2026 |